Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...

Fintel reports that on December 3, 2024, Wedbush downgraded their outlook for Cavco Industries (NasdaqGS:CVCO) from ...

Salesforce (CRM) is set to report fiscal third-quarter results tomorrow after the close of trading, and Wedbush Securities is ...

Investing.com -- Wedbush analysts expect tech stocks to end the year strongly with a “Santa rally,” citing positive catalysts ...

周五，Wedbush Securities维持了对苹果公司 (NASDAQ:AAPL)的积极立场，重申"优于大盘"评级和300.00美元的目标价。这一背书来自于这家科技巨头正进入关键的假日季，其市值现已达到3.55万亿美元，最新的iPhone ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

智通财经获悉， 赛富时 (CRM.US)将于北京时间周三晨间美股盘后公布第三财季业绩。Wedbush预计该公司公布“强劲”的业绩和指引。Wedbush分析师Dan Ives 维持了对赛富时的“跑赢大盘”评级和375美元的目标价，并补充说，该股是该公司 ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...

Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s TRACER platform. The investment firm said it believes TRACER alone should ...

12月4日｜Wedbush：将Zscaler的目标价从220美元上调至230美元，维持“跑赢大市”评级。() ...

Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.